United Therapeutics Corp (UTHR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1040 SPRING ST SILVER SPRING, MD 20910

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens - having a positive impact on patients, the environment and society - will sustain our success in the long term. Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.

Data as of 2021-05-08 10:21:45 -0400
Market Cap8.754 Billion Shares Outstanding44.796 Million Avg 30-day Volume301.663 Thousand
P/E Ratio21.59377 Dividend Yield EPS8.97
Price/Sales5.81 Debt to Equity1.35 EBITDA412.1 Million
Price to Book Value2.54 Forward PE15.89 Enterprise Value7.823 Billion
Total Cash1.731 Billion Current Debt302.4 Million Gross Profit1.398 Billion
BETA0.66524 52-week High/Low212.62 / 98.37 Next Earnings Date2021-07-28 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from UTHR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 13 9 44.44% 12 (0.72%) 8 (0.5%) 50.0%
Funds Holding: 349 326 7.06% 96 (5.77%) 97 (6.04%) -1.03%
13F shares: 42.791 Million 41.694 Million 2.63% 20.439 Million 18.623 Million 9.75%
% Ownership 96.2874 93.8187 2.63% 45.9907 41.9049 9.75%
New Positions: 67 43 55.81% 20 15 33.33%
Increased Positions 99 121 -18.18% 30 45 -33.33%
Closed Positions 42 58 -27.59% 19 25 -24.0%
Reduced Positions 138 117 17.95% 39 31 25.81%
Total Calls 247.129 Thousand 117.203 Thousand 110.86% 127.979 Thousand 52.4 Thousand 144.23%
Total Puts 100.868 Thousand 58 Thousand 73.91% 40.2 Thousand 28.3 Thousand 42.05%
PUT/CALL Ratio 0.41 0.49 -16.33% 0.31 0.54 -42.59%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding UTHR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding UTHR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.4 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

46.6 Thousand total shares from 13 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAHON PAUL A EVP & GENERAL COUNSEL

  • Officer
71,869 2021-05-06 12

PATUSKY CHRISTOPHER

  • Director
13,000 2021-05-06 4

DWEK RAYMOND

  • Director
0 2021-05-05 8

OLIAN JUDY D.

  • Director
5,790 2021-04-01 4

KURZWEIL RAY

  • Director
7,540 2021-03-26 2

THOMPSON TOMMY G

  • Director
18,840 2021-03-10 3

CAUSEY CHRISTOPHER

  • Director
825 2021-01-15 12

GILTNER RICHARD

  • Director
8,350 2021-01-06 6

BENKOWITZ MICHAEL PRESIDENT AND COO

  • Officer
1,998 2020-11-02 1

MAXWELL LINDA

  • Director
0 2020-09-10 2

ROTHBLATT MARTINE A CHAIRMAN & CEO

  • Officer
  • Director
664,185 2020-07-09 17

SULLIVAN LOUIS W

  • Director
9,420 2020-06-26 1

KLEIN KATHERINE J

  • Director
0 2020-06-26 1

MESA NILDA

  • Director
4,960 2020-06-26 1

EDGEMOND JAMES CFO AND TREASURER

  • Officer
753 2019-03-15 0

JEFFS ROGER

  • FORMER PRESIDENT AND CO-CEO
No longer subject to file 2016-06-27 0

ZACCARDELLI DAVID

  • FORMER EVP AND COO
No longer subject to file 2016-06-27 0

FERRARI JOHN MAXIM

  • FORMER CFO
No longer subject to file 2015-03-14 0

GRAY R PAUL

  • FORMER DIRECTOR
No longer subject to file 2014-03-18 0

LILLY ELI & CO

  • 10% Owner
5,251,394 2011-07-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PATUSKY CHRISTOPHER - Director by family trust

2021-05-10 16:31:31 -0400 2021-05-10 S 100 $190.52 d 1,200 indirect

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-05-10 16:32:55 -0400 2021-05-06 M 6,000 $94.96 a 42,369 direct yes

PATUSKY CHRISTOPHER - Director

2021-05-10 16:31:31 -0400 2021-05-06 D 2,500 $192.07 d 2,300 direct yes

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-05-10 16:32:55 -0400 2021-05-06 M 6,000 d 35,500 direct yes

PATUSKY CHRISTOPHER - Director

2021-05-10 16:31:31 -0400 2021-05-06 M 2,500 d 9,500 direct yes

PATUSKY CHRISTOPHER - Director

2021-05-10 16:31:31 -0400 2021-05-06 M 2,500 $63.90 a 4,800 direct yes

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-05-10 16:32:55 -0400 2021-05-06 D 6,000 $192.07 d 36,369 direct yes

DWEK RAYMOND - Director

2021-05-06 16:40:20 -0400 2021-05-05 M 2,000 d 0 direct yes

DWEK RAYMOND - Director

2021-05-06 16:40:20 -0400 2021-05-05 D 2,000 $198.14 d 0 direct yes

DWEK RAYMOND - Director

2021-05-06 16:40:20 -0400 2021-05-05 M 2,000 $54.77 a 2,000 direct yes

DWEK RAYMOND - Director

2021-04-29 16:32:52 -0400 2021-04-28 M 2,000 d 2,000 direct yes

DWEK RAYMOND - Director

2021-04-29 16:32:52 -0400 2021-04-28 D 2,000 $205.62 d 0 direct yes 0.1141 -3.0462 0.1141 2 -4.7083 5

DWEK RAYMOND - Director

2021-04-29 16:32:52 -0400 2021-04-28 M 2,000 $54.77 a 2,000 direct yes 0.1141 -3.0462 0.1141 2 -4.7083 5

DWEK RAYMOND - Director

2021-04-22 16:31:33 -0400 2021-04-21 M 2,000 d 4,000 direct yes

DWEK RAYMOND - Director

2021-04-22 16:31:33 -0400 2021-04-21 D 2,000 $211.93 d 0 direct yes 0.294 -2.8627 0.294 2 -2.8627 6

DWEK RAYMOND - Director

2021-04-22 16:31:33 -0400 2021-04-21 M 2,000 $54.77 a 2,000 direct yes 0.294 -2.8627 0.294 2 -2.8627 6

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-16 16:33:47 -0400 2021-04-15 M 6,000 d 41,500 direct yes

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-16 16:33:47 -0400 2021-04-15 D 6,000 $201.67 d 36,369 direct yes 1.8348 2.0948 3.9688 3 0.0 1

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-16 16:33:47 -0400 2021-04-15 M 6,000 $94.96 a 42,369 direct yes 1.8348 2.0948 3.9688 3 0.0 1

DWEK RAYMOND - Director

2021-04-15 16:32:43 -0400 2021-04-14 M 2,000 d 6,000 direct yes

DWEK RAYMOND - Director

2021-04-15 16:32:43 -0400 2021-04-14 D 2,000 $202.78 d 0 direct yes 0.054 1.8505 4.0249 4 0.0 1

DWEK RAYMOND - Director

2021-04-15 16:32:43 -0400 2021-04-14 M 2,000 $54.77 a 2,000 direct yes 0.054 1.8505 4.0249 4 0.0 1

DWEK RAYMOND - Director

2021-04-08 17:26:06 -0400 2021-04-07 M 2,000 d 8,000 direct yes

DWEK RAYMOND - Director

2021-04-08 17:26:06 -0400 2021-04-07 D 2,000 $191.10 d 0 direct yes -2.3456 0.1819 0.1819 6 -2.3456 2

DWEK RAYMOND - Director

2021-04-08 17:26:06 -0400 2021-04-07 M 2,000 $54.77 a 2,000 direct yes -2.3456 0.1819 0.1819 6 -2.3456 2

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-02 09:35:05 -0400 2021-04-01 M 6,000 d 47,500 direct yes

OLIAN JUDY D. - Director

2021-04-02 09:33:47 -0400 2021-04-01 M 4,207 d 0 direct yes

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-02 09:35:05 -0400 2021-04-01 D 6,000 $192.34 d 36,369 direct yes -0.5707 3.0298 5.5045 5 -0.856 3

OLIAN JUDY D. - Director

2021-04-02 09:33:47 -0400 2021-04-01 S 4,207 $184.96 d 5,790 direct yes -0.5707 3.0298 5.5045 5 -0.856 3

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-04-02 09:35:05 -0400 2021-04-01 M 6,000 $94.96 a 42,369 direct yes -0.5707 3.0298 5.5045 5 -0.856 3

OLIAN JUDY D. - Director

2021-04-02 09:33:47 -0400 2021-04-01 M 4,207 $76.36 a 9,997 direct yes -0.5707 3.0298 5.5045 5 -0.856 3

KURZWEIL RAY - Director

2021-03-29 16:31:29 -0400 2021-03-26 M 3,750 d 0 direct

KURZWEIL RAY - Director

2021-03-29 16:31:29 -0400 2021-03-26 D 3,750 $171.21 d 7,540 direct 1.0878 15.4892 16.4864 4 0.0 1

KURZWEIL RAY - Director

2021-03-29 16:31:29 -0400 2021-03-26 M 3,750 $54.77 a 11,290 direct 1.0878 15.4892 16.4864 4 0.0 1

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-03-19 16:32:59 -0400 2021-03-18 M 6,000 d 53,500 direct yes

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-03-19 16:32:59 -0400 2021-03-18 D 6,000 $170.35 d 36,369 direct yes -2.0373 0.6712 16.043 25.8791 22 -2.4828 3

MAHON PAUL A - Officer EVP & GENERAL COUNSEL

2021-03-19 16:32:59 -0400 2021-03-18 M 6,000 $94.96 a 42,369 direct yes -2.0373 0.6712 16.043 25.8791 22 -2.4828 3

OLIAN JUDY D. - Director

2021-03-19 16:32:03 -0400 2021-03-17 M 2,103 $76.36 a 7,893 direct yes -2.0373 0.6712 16.043 25.8791 22 -2.4828 3

OLIAN JUDY D. - Director

2021-03-19 16:32:03 -0400 2021-03-17 M 2,103 d 4,207 direct yes

OLIAN JUDY D. - Director

2021-03-19 16:32:03 -0400 2021-03-17 S 2,103 $170.00 d 5,790 direct yes -2.0373 0.6712 16.043 25.8791 22 -2.4828 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
UNITED THERAPEUTICS CORP UTHR 2021-05-10 22:15:04 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 21:45:02 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 21:15:02 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 20:45:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 20:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 19:45:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 19:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 18:45:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 18:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 17:45:02 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 17:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 16:45:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 16:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 15:45:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 15:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 14:45:04 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 14:15:04 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 13:45:04 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 13:15:03 UTC -0.3581 0.4081 1900000
UNITED THERAPEUTICS CORP UTHR 2021-05-10 12:45:02 UTC -0.3581 0.4081 1900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund UTHR -7.0 shares, $-663.78 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund UTHR -11.0 shares, $-1043.08 2020-03-31 N-PORT
UBS RELATIONSHIP FUNDS- UBS U.S. EQUITY ALPHA RELATIONSHIP FUND UTHR -7611.0 shares, $-920931.0 2020-06-30 N-PORT

Elevate your investments